المؤلفون: Rezazadeh Kalebasty, Arash, Benjamin, David J., Loriot, Yohann, Papantoniou, Dimitrios, Siefker-Radtke, Arlene O., Necchi, Andrea, Naini, Vahid, Carcione, Jenna Cody, Santiago-Walker, Ademi, Triantos, Spyros, Burgess, Earle F.

المصدر: European Urology Open Science ; volume 47, page 48-57 ; ISSN 2666-1683

مصطلحات موضوعية: Urology

الإتاحة: https://doi.org/10.1016/j.euros.2022.11.001Test
https://api.elsevier.com/content/article/PII:S2666168322026817?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666168322026817?httpAccept=text/plainTest

المؤلفون: Catto, James WF, Hussain, Syed A, Tran, Ben, Pignot, Geraldine, Master, Viraj, Rouprêt, Morgan, Tubaro, Andrea, Shimizu, Nobuaki, Vasdev, Nikhil, Nishiyama, Hiroyuki, Daneshmand, Siamak, Miura, Yuji, Chlosta, Piotr L, Cutuli, Hernan J, Luz, Murilo Almeida, Crow, Lauren, Naini, Vahid, Triantos, Spyros, Baig, Mahadi, Steinberg, Gary

المصدر: Urologic Oncology: Seminars and Original Investigations ; volume 42, page S53 ; ISSN 1078-1439

مصطلحات موضوعية: Urology, Oncology

الإتاحة: https://doi.org/10.1016/j.urolonc.2024.01.161Test
https://api.elsevier.com/content/article/PII:S1078143924001777?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1078143924001777?httpAccept=text/plainTest

المؤلفون: Daneshmand, Siamak, Zaucha, Renata, Vasdev, Nikhil, Gartrell, Benjamin A, Lotan, Yair, Hussain, Syed A, Lee, Eugene K, Procopio, Giuseppe, Galanternik, Fernando, Pignot, Geraldine, Sundi, Debasish, Cutuli, Hernan J, Crow, Lauren, Naini, Vahid, Triantos, Spyros, Baig, Mahadi, Maranchie, Jodi K

المصدر: Urologic Oncology: Seminars and Original Investigations ; volume 42, page S58 ; ISSN 1078-1439

مصطلحات موضوعية: Urology, Oncology

الإتاحة: https://doi.org/10.1016/j.urolonc.2024.01.172Test
https://api.elsevier.com/content/article/PII:S1078143924001881?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1078143924001881?httpAccept=text/plainTest

المؤلفون: Morris, Michael J, Molina, Arturo, Small, Eric J, de Bono, Johann S, Logothetis, Christopher J, Fizazi, Karim, de Souza, Paul, Kantoff, Philip W, Higano, Celestia S, Li, Jinhui, Kheoh, Thian, Larson, Steven M, Matheny, Shannon L, Naini, Vahid, Burzykowski, Tomasz, Griffin, Thomas W, Scher, Howard I, Ryan, Charles J

المصدر: Journal of Clinical Oncology. 33(12)

مصطلحات موضوعية: Urologic Diseases, Clinical Trials and Supportive Activities, Prostate Cancer, Cancer, Clinical Research, Abiraterone Acetate, Androstenes, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Bone Neoplasms, Disease-Free Survival, Double-Blind Method, Humans, Male, Neoplasm Metastasis, Prednisone, Prostatic Neoplasms, Castration-Resistant, Radiography, Survival Rate, Treatment Outcome, Clinical Sciences, Oncology and Carcinogenesis, Oncology & Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/1zq6j6ngTest

المؤلفون: Chi, Kim N, Agarwal, Neeraj, Bjartell, Anders, Chung, Byung Ha, Pereira de Santana Gomes, Andrea J, Given, Robert, Juárez Soto, Álvaro, Merseburger, Axel S, Özgüroğlu, Mustafa, Uemura, Hirotsugu, Ye, Dingwei, Deprince, Kris, Naini, Vahid, Li, Jinhui, Cheng, Shinta, Yu, Margaret K, Zhang, Ke, Larsen, Julie S, McCarthy, Sharon, Chowdhury Simon, TITAN Investigators, Sciarra Alessandro

المساهمون: Chi, Kim N, Agarwal, Neeraj, Bjartell, Ander, Chung, Byung Ha, Pereira de Santana Gomes, Andrea J, Given, Robert, Juárez Soto, Álvaro, Merseburger, Axel S, Özgüroğlu, Mustafa, Uemura, Hirotsugu, Ye, Dingwei, Deprince, Kri, Naini, Vahid, Li, Jinhui, Cheng, Shinta, Yu, Margaret K, Zhang, Ke, Larsen, Julie S, Mccarthy, Sharon, Chowdhury, Simon, Titan, Investigator, Sciarra, Alessandro

مصطلحات موضوعية: prostate cancer, apalutamide, hormone therapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31150574; info:eu-repo/semantics/altIdentifier/wos/WOS:000474094900008; volume:381; issue:1; firstpage:13; lastpage:24; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11573/1294771Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85068436470

الإتاحة: https://doi.org/10.1056/NEJMoa1903307Test
http://hdl.handle.net/11573/1294771Test

المؤلفون: Ye, Dingwei, Huang, Yiran, Zhou, Fangjian, Xie, Keji, Matveev, Vsevolod, Li, Changling, Alexeev, Boris, Tian, Ye, Qiu, Mingxing, Li, Hanzhong, Zhou, Tie, De Porre, Peter, Yu, Margaret, Naini, Vahid, Liang, Hongchuan, Wu, Zhuli, Sun, Yinghao

المساهمون: Janssen Research & Development, LLC

المصدر: Asian Journal of Urology ; volume 4, issue 2, page 75-85 ; ISSN 2214-3882

الإتاحة: https://doi.org/10.1016/j.ajur.2017.01.002Test
https://api.elsevier.com/content/article/PII:S2214388217300164?httpAccept=text/plainTest
https://api.elsevier.com/content/article/PII:S2214388217300164?httpAccept=text/xmlTest

المؤلفون: Catto, James W.F., Tran, Ben, Roupret, Morgan, Gschwend, Juergen E., Loriot, Yohann, Nishiyama, Hiroyuki, Redorta, Joan P., Daneshmand, Siamak, Hussain, Syed A., Cutuli, Hernan J, Procopio, Giuseppe, Guadalupi, Valentina, Vasdev, Nikhil, Naini, Vahid, Crow, Lauren, Triantos, Spyros, Baig, Mahadi, Steinberg, Gary D.

المساهمون: Department of Clinical, Pharmaceutical and Biological Science, Extracellular Vesicle Research Unit, Basic and Clinical Science Unit, Centre for Health Services and Clinical Research, School of Life and Medical Sciences

مصطلحات موضوعية: FGFR, erdafitinib, intravesical chemotherapy, non-muscle-invasive bladder cancer, recurrence-free survival, safety, Hematology, Oncology

العلاقة: Annals of Oncology; Catto , J W F , Tran , B , Roupret , M , Gschwend , J E , Loriot , Y , Nishiyama , H , Redorta , J P , Daneshmand , S , Hussain , S A , Cutuli , H J , Procopio , G , Guadalupi , V , Vasdev , N , Naini , V , Crow , L , Triantos , S , Baig , M & Steinberg , G D 2024 , ' Erdafitinib in BCG-treated high risk non-muscle invasive bladder cancer ' , Annals of Oncology , vol. 35 , no. 1 , pp. 98-106 . https://doi.org/10.1016/j.annonc.2023.09.3116Test; http://hdl.handle.net/2299/27518Test; http://www.scopus.com/inward/record.url?scp=85175616619&partnerID=8YFLogxKTest

الإتاحة: http://hdl.handle.net/2299/27518Test
http://www.scopus.com/inward/record.url?scp=85175616619&partnerID=8YFLogxKTest

المؤلفون: Agarwal, Neeraj, McQuarrie, Kelly, Bjartell, Anders, Chowdhury, Simon, Pereira de Santana Gomes, Andrea J., Chung, Byung Ha, Özgüroğlu, Mustafa, Juárez Soto, Álvaro, Merseburger, Axel S., Uemura, Hirotsugu, Ye, Dingwei, Given, Robert, Cella, David, Basch, Ethan, Miladinovic, Branko, Dearden, Lindsay, Deprince, Kris, Naini, Vahid, Lopez-Gitlitz, Angela, Chi, Kim N.

المصدر: The Lancet Oncology BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation EpiHealth: Epidemiology for Health. 20(11):1518-1530

مصطلحات موضوعية: Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicinska och farmaceutiska grundvetenskaper, Farmakologi och toxikologi, Basic Medicine, Pharmacology and Toxicology

الوصول الحر: https://lup.lub.lu.se/record/91b5e8fc-ad23-42d0-97b9-3a3695b812edTest
http://dx.doi.org/10.1016/S1470-2045Test(19)30620-5

المؤلفون: Catto, James W.F., Tran, Ben, Master, Viraj A., Roupret, Morgan, Pignot, Geraldine, Tubaro, Andrea, Shimizu, Nobuaki, Vasdev, Nikhil, Gschwend, Juergen, Loriot, Yohann, Nishiyama, Hiyoyuki, Redorta, Joan, Daneshmand, Siamak, Miura, Yuji, Naini, Vahid, Crow, Lauren, Triantos, Spyros, Baig, Mahadi, Steinberg, Gary D.

المساهمون: Centre for Health Services and Clinical Research, Basic and Clinical Science Unit, Extracellular Vesicle Research Unit, Department of Clinical, Pharmaceutical and Biological Science, School of Life and Medical Sciences

العلاقة: Catto , J W F , Tran , B , Master , V A , Roupret , M , Pignot , G , Tubaro , A , Shimizu , N , Vasdev , N , Gschwend , J , Loriot , Y , Nishiyama , H , Redorta , J , Daneshmand , S , Miura , Y , Naini , V , Crow , L , Triantos , S , Baig , M & Steinberg , G D 2023 , ' Phase 2 Study of the Efficacy and Safety of Erdafitinib in Patients With Bacillus Calmette-Guérin (BCG)-Unresponsive, High-Risk Non–Muscle-Invasive Bladder Cancer (HR-NMIBC) With FGFR3/2 Alterations (alt) in THOR-2: Cohort 2 Interim Analysis Results ' , ASCO Genitourinary Cancers Symposium , United States , 16/02/23 - 18/02/23 .; conference; http://hdl.handle.net/2299/26606Test

الإتاحة: http://hdl.handle.net/2299/26606Test

المؤلفون: Ryan, Charles J, Smith, Matthew R, Fizazi, Karim, Saad, Fred, Mulders, Peter F A, Sternberg, Cora N, Miller, Kurt, Logothetis, Christopher J, Shore, Neal D, Small, Eric J, Carles, Joan, Flaig, Thomas W, Taplin, Mary-Ellen, Higano, Celestia S, de Souza, Paul, de Bono, Johann S, Griffin, Thomas W, De Porre, Peter, Yu, Margaret K, Park, Youn C, Li, Jinhui, Kheoh, Thian, Naini, Vahid, Molina, Arturo, Rathkopf, Dana E

المساهمون: Bjartell, Anders, Creator

المصدر: The Lancet Oncology EpiHealth: Epidemiology for Health BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation. 16(2):60-152

مصطلحات موضوعية: Aged, Androstenes/therapeutic use, Antineoplastic Agents, Hormonal/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Bone Neoplasms/drug therapy, Disease Progression, Double-Blind Method, Follow-Up Studies, Humans, Male, Neoplasm Staging, Prednisone/therapeutic use, Prognosis, Prostatic Neoplasms, Castration-Resistant/drug therapy, Survival Rate, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology

الوصول الحر: https://lup.lub.lu.se/record/5efd6db3-607a-4d21-9c64-cecf189d59d9Test
http://dx.doi.org/10.1016/S1470-2045Test(14)71205-7